http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009239851-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567137184001ee870487f2e4b0a4b475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd0d7efba3b54c48d23e2e3bf2e105f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7398748eff1c3fb690f53204673e21f4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate | 2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae0c418e449a4f805b1587b1d09488f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02778c8b23b952f30a38478abcda57a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73fa4b96d3d7e118d26f402c7692f965 |
| publicationDate | 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2009239851-A1 |
| titleOfInvention | Benzothiazinone Derivatives and their Use as Antibacterial Agents |
| abstract | The present invention relates to novel benzothiazin derivatives and their use as antibacterial agents in infectious diseases of mammals (humans and animals) caused by bacteria, especially diseases like tuberculosis (TB) and leprosy caused by mycobacteria. n The present invention aims at the generation of new compounds with activity against mycobacteria as potential new tuberculosis drugs to overcome problems concerning resistance and drug intolerance. n The solution of the present invention is a compound of the formula I n n n n n n n n n n n n wherein R 1 and R 2 are, independently each from other, NO 2 , CN, CONR 7 R 8 , COOR 9 , CHO, halogen, NR 7 R 8 , SO 2 NR 7 R 8 , SR 9 , OCF 3 , mono-, di or trifluoromethyl; n R 3 and R 4 are, independently each from other, H, a saturated or unsaturated, linear or branched aliphatic radical having 1-7 chain members, cycloalkyl having 3-6 carbon atoms, benzyl, SR 9 , OR 9 ; n R 5 and R 6 are, independently each from other, a saturated or unsaturated, halogenated or unhalogenated, linear or branched aliphatic radical having 1-8 chain members, cycloalkyl having 3-6 carbon atoms, phenyl, or R 5 and R 6 together represent a bivalent radical —(CR 9 2 ) m —, or R 5 and R 6 together represent bivalent radicals: n n n n n n n n n n n n n n n n wherein m is 1-4, or represent bivalent radicals a saturated or unsaturated mono or polyheterocycles with heteroatoms N, S, O and substituted by (R 10 )x, wherein x is 1-4; n R 7 , R 8 and R 9 are, independently each from other H or a saturated or unsaturated, halogenated or unhalogenated, linear or branched aliphatic radical having 1-7 chain members, mono-, di or trifluoromethyl, halogen, phenyl, or R 3 and R 4 together represent a bivalent radical —(CH 2 ) n — wherein n is 2-7; n R 10 is H or a saturated or unsaturated, halogenated or unhalogenated, linear or branched aliphatic radical having 1-7 chain members, NO 2 , NR 7 R 8 , CN, CONR 7 R 8 , COOR 9 , CHO, halogen, SO 2 NR 7 R 8 , SR 9 , OR 9 , OCF 3 , mono-, di or trifluoromethyl, benzyl or phenyl. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102276598-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102276598-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796264-B2 |
| priorityDate | 2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 231.